Agilis is your trusted human factors partner and end to end solutions provider for the life sciences industry.  For the last 20 years we have helped new and established companies achieve successful human factors submissions while navigating the complex global regulatory landscape, resulting in safe and effective medical devices and combination products. 

Agilis by Kymanox

We are pleased to announce our acquisition and partnership with Kymanox Corporation in February 2023. Kymanox was founded in 2004 and is headquartered in Morrisville, North Carolina USA. Kymanox is a life science professional services organization that offers engineering, scientific, project management, quality, human factors, testing / quality control (QC), commissioning, qualification, and validation (CQV), and regulatory support to companies exclusively in the biotechnology, pharmaceutical, medical device, and combination product industries. With its diverse team of over 275 experts, Kymanox helps clients navigate commercialization challenges that arise throughout a product’s life cycle, from early development to post- market, with optimized safety, quality, efficacy, and accessibility.

The strength of the combined companies service offerings and office locations will be a tremendous benefit in the support of helping bring biologics (including biosimilars and Cell & Gene Therapies), pharmaceuticals, drug/device combinations products, and medical devices to markets worldwide. This acquisition allows us to be able to provide you expanded end-to-end life science solutions and further areas of expertise, as well as significantly expanded geographic reach. 

Explore Agilis